» Articles » PMID: 31705334

Early Integration of Design of Experiment (DOE) and Multivariate Statistics Identifies Feeding Regimens Suitable for CHO Cell Line Development and Screening

Overview
Journal Cytotechnology
Specialties Biotechnology
Genetics
Date 2019 Nov 10
PMID 31705334
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

In Chinese Hamster Ovary (CHO) cell lines, the establishment of the ideal fed-batch regimen promotes metabolic conditions advantageous for the bioproduction of therapeutic molecules. A tailored, cell line-specific feeding scheme is typically defined during process development (PD) activities, through the incorporation of Design of Experiment (DOE) and late stage cell culture approaches. The feeding during early stage cell line development (CLD) was a simplified "one-fits-all" design, inherited from PD lab, that didn't account for CLD needs of throughput and streamlined workflow. The "one-fits-all" efficiency was not routinely verified when novel technologies were incorporated in CLD and sub-optimal feeding carried the risk of not selecting the most desirable cell lines amenable to late stage PD. In our work we developed the DOE-feed method; a streamlined, three-stages framework for identifying efficient feeding schemes as the CLD technologies evolved. We combined early stage cell culture input data with late-stage techniques, such as statistical modelling, principal component analysis (PCA), DOE and Prediction Profiler. Novel in our DOE-feed work, we deliberately anticipated the application of statistics and approached the method development as an early-stage, continuously updated process, by building iterative datasets and statistically interpreting their responses. We capitalized on the statistical models defined by the DOE-feed methodology to study the influence of feeds on daily productivity and growth and to extrapolate feeding-schemes that improved the cell line screening. The DOE-feed became a methodology suited for CLD needs at AbbVie, and optimized the early stage screening, reduced the operational hands-on time and improved the overall workstream efficiency.

Citing Articles

From Efficiency to Yield: Exploring Recent Advances in CHO Cell Line Development for Monoclonal Antibodies.

Majumdar S, Desai R, Hans A, Dandekar P, Jain R Mol Biotechnol. 2024; 67(2):369-392.

PMID: 38363529 DOI: 10.1007/s12033-024-01060-6.


Clever Experimental Designs: Shortcuts for Better iPSC Differentiation.

Yasui R, Sekine K, Taniguchi H Cells. 2021; 10(12).

PMID: 34944048 PMC: 8700474. DOI: 10.3390/cells10123540.

References
1.
Porter A, Racher A, Preziosi R, Dickson A . Strategies for selecting recombinant CHO cell lines for cGMP manufacturing: improving the efficiency of cell line generation. Biotechnol Prog. 2010; 26(5):1455-64. DOI: 10.1002/btpr.443. View

2.
Templeton N, Dean J, Reddy P, Young J . Peak antibody production is associated with increased oxidative metabolism in an industrially relevant fed-batch CHO cell culture. Biotechnol Bioeng. 2013; 110(7):2013-24. DOI: 10.1002/bit.24858. View

3.
Lindgren K, Salmen A, Lundgren M, Bylund L, Ebler A, Faldt E . Automation of cell line development. Cytotechnology. 2009; 59(1):1-10. PMC: 2677144. DOI: 10.1007/s10616-009-9187-y. View

4.
Charaniya S, Le H, Rangwala H, Mills K, Johnson K, Karypis G . Mining manufacturing data for discovery of high productivity process characteristics. J Biotechnol. 2010; 147(3-4):186-97. DOI: 10.1016/j.jbiotec.2010.04.005. View

5.
Ho S, Yang Y . Identifying and engineering promoters for high level and sustainable therapeutic recombinant protein production in cultured mammalian cells. Biotechnol Lett. 2014; 36(8):1569-79. DOI: 10.1007/s10529-014-1523-4. View